Drug research

Setrusumab

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as BPS804; UX143

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis ImperfectaNCT05312697	RARE	Phase 2	Terminated	2022-07-07Actual
Setrusumab vs Placebo for Osteogenesis ImperfectaNCT05125809	RARE	Phase 2, Phase 3	Active not recruiting	2025-10-20Actual
Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaNCT05768854	RARE	Phase 3	Active not recruiting	2025-10-23Actual

RARETerminatedPrimary completion: 2022-07-07 · Actual

Trial details

RAREActive not recruitingPrimary completion: 2025-10-20 · Actual

Trial details

RAREActive not recruitingPrimary completion: 2025-10-23 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.